masticadienonic acid
from Pistacia terebinthus galls; structure in first source
Networked: 5
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Benarous, Khedidja:
1 article
(06/2021)
|
2. | Maamri, Sarra:
1 article
(06/2021)
|
3. | Yousfi, Mohamed:
1 article
(06/2021)
|
4. | Apan, Teresa Ramírez:
1 article
(09/2005)
|
5. | Chávez, Ibeth Oviedo:
1 article
(09/2005)
|
6. | Martínez-Vázquez, Mariano:
1 article
(09/2005)
|
7. | Amalric, F:
1 article
(05/2005)
|
8. | Ausseil, F:
1 article
(05/2005)
|
9. | Benaim, P:
1 article
(05/2005)
|
10. | Bieth, A:
1 article
(05/2005)
|
Related Diseases
1. | Neoplasms (Cancer)
|
2. | Leishmaniasis
|
3. | Colitis
|
4. | Alzheimer Disease (Alzheimer's Disease)
01/01/2023
- " The molecular docking results of 3-methoxycarpachromene, masticadienonic acid, 7-ethoxycoumarin, 3',5,7-trihydroxy-4'-methoxyflavanone and 5,6,7,4'-tetrahydroxyflavonol-3-Orutinoside with the five enzymes show significant affinities of these molecules towards Alzheimer disease targets, where they could form several interactions, such as hydrogen bonds and hydrophobic interactions with the studied enzymes. "
|
|
Related Drugs and Biologics